Insulin Delivery Systems: Do They Need a Glucose Sensor?

New systems are being developed for continuous insulin infusion in diabetes mellitus. Of these, the bedside closed-loop system (artificial B-cell) normalizes measured blood glucose in the fasting and fed states, while favorably altering other fuel substrates and hormone levels in short-term studies of 1–2 days. More recent portable, external open-loop insulin delivery systems have been developed which can be programmed to achieve similar results in long-term studies in animals and humans. This is accomplished without the need for continuous glucose sensing. The partial metabolic normalization achieved is not compromised by physical exercise, and unacceptably low blood glucose levels are rarely observed. Further development and application of these new systems will enable researchers to establish whether the achievement of ideal metabolic control in diabetes can be realized with or without sensors for glucose or other metabolites.

[1]  A. Albisser,et al.  A physiological solvent for crystalline insulin , 2004, Diabetologia.

[2]  W Zingg,et al.  Clinical Control of Diabetes by the Artificial Pancreas , 1974, Diabetes.

[3]  E. Kraegen,et al.  Control of blood glucose in diabetics using an artificial pancreas. , 1977, Australian and New Zealand journal of medicine.

[4]  W. Zingg,et al.  An all-plastic double-lumen catheter for continuous blood sampling. , 1975, Medical instrumentation.

[5]  B. Zinman,et al.  Insulinoma Resection Facilitated by the Artificial Endocrine Pancreas , 1978, Diabetes.

[6]  A. Albisser,et al.  New Devices and Methods for Long-term Vascular Access for Blood Sampling and Insulin Infusion , 1980, Diabetes Care.

[7]  Charles K. Botz.  An Improved Control Algorithm for an Artificial ß-Cell , 1976, IEEE Transactions on Biomedical Engineering.

[8]  G. Slama,et al.  One to Five Days of Continuous Intravenous Insulin Infusion on Seven Diabetic Patients , 1974, Diabetes.

[9]  U. Fischer,et al.  Derivation and experimental proof of a new algorithm for the artificial B-cell based on the individual analysis of the physiological insulin-glucose relationship. , 1978, Endokrinologie.

[10]  D. Gough,et al.  Effect of coreactants on electrochemical glucose oxidation , 1978 .

[11]  A H Clemens,et al.  The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  A M Albisser,et al.  Glycemic Regulation Using a Programmed Insulin Delivery Device: III. Long-Term Studies on Diabetic Dogs , 1979, Diabetes.

[13]  B. Zinman,et al.  Glucoregulation during moderate exercise in insulin treated diabetics. , 1977, The Journal of clinical endocrinology and metabolism.

[14]  M. T. Brennan,et al.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. , 1967, The Journal of clinical investigation.

[15]  G. Grodsky,et al.  Dynamics of insulin secretion by the perfused rat pancreas. , 1968, Endocrinology.

[16]  B S Leibel,et al.  The metabolic response to glycemic control by the artificial pancreas in diabetic man. , 1979, Metabolism: clinical and experimental.

[17]  R. D. Schultz,et al.  Continuous Extracorporeal Monitoring of Animal Blood Using the Glucose Electrode , 1976, Diabetes.

[18]  S. Genuth,et al.  Control of Hyperglycemia in Adult Diabetics by Pulsed Insulin Delivery , 1977, Diabetes.

[19]  H. Knowles,et al.  A Plea for Plasma Sugar , 1965, Diabetes.

[20]  Y. Yamasaki,et al.  Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell. , 1978, Acta endocrinologica.

[21]  J. Hiebert,et al.  Progress Towards an Implantable Glucose Sensor and an Artificial Beta Cell , 1973 .

[22]  J. Pickup,et al.  continuous Subcutaneous Insulin Infusion in the Treatment of Diabetes Mellitus , 1980, Diabetes Care.

[23]  W. Tamborlane,et al.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.

[24]  A. Schiffrin,et al.  Combined Continuous Subcutaneous Insulin Infusion and Multiple Subcutaneous Injections in Type I Diabetic Patients , 1981, Diabetes Care.

[25]  B. Zinman,et al.  The metabolic response to moderate exercise in diabetic man receiving intravenous and subcutaneous insulin. , 1977, The Journal of clinical endocrinology and metabolism.

[26]  A. Coran,et al.  Total parenteral nutrition in infants and children: central and peripheral approaches. , 1976, The Surgical clinics of North America.

[27]  A E Lambert,et al.  Determination of Insulin Requirements in Brittle Diabetic Patients by the Artificial Pancreas , 1978, Diabetes.

[28]  B. Zinman,et al.  Normalization of Glycemia in Diabetics During Meals with Insulin and Glucagon Delivery by the Artificial Pancreas , 1977, Diabetes.

[29]  B. Zinman,et al.  ROLE OF CONTINUOUS COMPONENT IN SUBCUTANEOUS "OPEN-LOOP" INSULIN DELIVERY , 1980, The Lancet.

[30]  F. Service.  Normalization of plasma glucose of unstable diabetes: studies under ambulatory, fed conditions with pumped intravenous insulin. , 1978, The Journal of laboratory and clinical medicine.